secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protagonist Therapeutics, Inc (PTGX)
CIK:        0001377121
Form:       8-K
Filed at:   2023-03-10T23:59:59+00:00
Accession:  0001104659-23-031135
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Protagonist Therapeutics discloses limited SVB exposure, $13M at risk out of $231M total
--------------------------------------------------------------------------------

- Cash at SVB approximately $13M as of March 9, 2023; company considers exposure limited.
- Third-party investments of ~$218M held at multiple custodians are not directly exposed to SVB liquidity concerns.
- Total cash and investments approximately $231M; company notes multiple custodians reduce risk.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1377121/000110465923031135/0001104659-23-031135-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1377121/000110465923031135/tm239184d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-031135

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer